Inductive Bio is a technology company developing a machine learning (ML) platform designed to dramatically accelerate the compound optimization process, a critical and time-consuming step in developing new therapeutics. By building datasets and state-of-the-art ML models designed to map the drivers of small molecule Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET), Inductive's platform allows scientists to optimize initial compounds into leads and development candidates faster and with a better balance of ADMET properties.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/13/23	$4,300,000	Seed	AlleyCorp Andreessen Horowitz Bessemer Venture Partners Character Lux Capital	undisclosed